Breaking News Instant updates and real-time market news.

SELB

Selecta Biosciences

$13.37

-0.43 (-3.12%)

07:25
10/23/18
10/23
07:25
10/23/18
07:25

Selecta Biosciences to host conference call

Management discusses the Phase 2 data for SEL-212 presented at the 2018 ACR Annual Meeting on a conference call to be held on October 23 at 8 am. Webcast Link

  • 23

    Oct

SELB Selecta Biosciences
$13.37

-0.43 (-3.12%)

10/18/18
MZHO
10/18/18
NO CHANGE
Target $30
MZHO
Buy
SEL-403 safety issues unlikely a read through to SEL-212, says Mizuho
Selecta Biosciences last night disclosed a patient death related to pneumonitis in a Phase 1 clinical trial of SEL-403 conducted at the National Cancer Institute for the treatment of mesothelioma, Mizuho analyst Difei Yang tells investors in a research note. The analyst does not believe there is a read-through between SEL-212 and SEL-403 given that the patient had received multiple courses of immune checkpoint inhibitors and radiation which are known to cause pneumonitis and that no cases of pneumonitis have been observed in 150-plus patients treated with SEL-212 to-date. Further, the analyst, who spoke to management last night, says she's not aware of a clinical hold on the SEL-403 trial so far. Yang reiterates a Buy rating on Selecta with a $30 price target.
10/17/18
MZHO
10/17/18
NO CHANGE
Target $30
MZHO
Buy
Selecta Biosciences upcoming data likely a catalyst, says Mizuho
Selecta Biosciences will present data from the Phase 2 trial of SEL-212 for the five monthly dose cohorts at the American College of Rheumatology meeting on October 23, Mizuho analyst Difei Yang tells investors in a research note. The analyst thinks the data will likely a catalyst for the shares and views the probability of success as favorable. She reiterates a Buy rating on Selecta Biosciences with a $30 price target.
09/13/18
STFL
09/13/18
INITIATION
STFL
Buy
Selecta Biosciences resumed with a Buy at Stifel
Stifel analyst Derek Archila resumed coverage of Selecta Biosciences with a Buy rating and $24 price target, saying he believes SEL-212's clinical data suggests an improved efficacy/tolerability profile and less frequent dosing than the current standard of care for severe chronic gout.
06/27/18
JANY
06/27/18
INITIATION
Target $33
JANY
Buy
Selecta Biosciences initiated with a Buy at Janney Montgomery Scott
Janney Montgomery Scott analyst Yun Zhong initiated Selecta Biosciences with a Buy rating and $33 fair value estimate.

TODAY'S FREE FLY STORIES

DRH

DiamondRock

$9.88

-0.165 (-1.64%)

06:41
12/11/18
12/11
06:41
12/11/18
06:41
Downgrade
DiamondRock rating change  »

DiamondRock downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ASR

Asur

$142.35

2.27 (1.62%)

06:40
12/11/18
12/11
06:40
12/11/18
06:40
Upgrade
Asur rating change  »

Citi upgrades Asur to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WEX

Wex

$152.58

-0.875 (-0.57%)

, FLT

FleetCor

$186.15

-0.78 (-0.42%)

06:39
12/11/18
12/11
06:39
12/11/18
06:39
Downgrade
Wex, FleetCor rating change  »

Wex, FleetCor downgraded…

WEX

Wex

$152.58

-0.875 (-0.57%)

FLT

FleetCor

$186.15

-0.78 (-0.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 12

    Dec

MKTAY

Makita

$0.00

(0.00%)

06:38
12/11/18
12/11
06:38
12/11/18
06:38
Upgrade
Makita rating change  »

Makita upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BHGE

Baker Hughes

$21.27

-0.38 (-1.76%)

06:36
12/11/18
12/11
06:36
12/11/18
06:36
Conference/Events
Baker Hughes management to meet with Evercore ISI »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 13

    Dec

  • 18

    Dec

RHHBY

Roche

$0.00

(0.00%)

06:36
12/11/18
12/11
06:36
12/11/18
06:36
Recommendations
Roche analyst commentary  »

Citi closes positive…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 13

    Dec

  • 24

    Dec

  • 18

    Mar

BTC

Bitcoin

$0.00

(0.00%)

, BITCOIN

Bitcoin

$0.00

(0.00%)

06:36
12/11/18
12/11
06:36
12/11/18
06:36
Periodicals
Samsung may be working on a blockchain phone, TNW reports »

Samsung has filed three…

BTC

Bitcoin

$0.00

(0.00%)

BITCOIN

Bitcoin

$0.00

(0.00%)

SSNLF

Samsung

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NOK

Nokia

$5.68

0.14 (2.53%)

06:35
12/11/18
12/11
06:35
12/11/18
06:35
Recommendations
Nokia analyst commentary  »

Nokia added to US 1 List…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BGNE

BeiGene

$136.19

-1.41 (-1.02%)

06:35
12/11/18
12/11
06:35
12/11/18
06:35
Conference/Events
BeiGene management to meet with Leerink »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 12

    Dec

ESS

Essex Property Trust

$262.73

-1.04 (-0.39%)

, AIV

Aimco

$47.03

-0.04 (-0.08%)

06:34
12/11/18
12/11
06:34
12/11/18
06:34
Upgrade
Essex Property Trust, Aimco, AvalonBay, Invitation Homes rating change  »

Essex Property Trust…

ESS

Essex Property Trust

$262.73

-1.04 (-0.39%)

AIV

Aimco

$47.03

-0.04 (-0.08%)

AVB

AvalonBay

$187.46

-1.21 (-0.64%)

INVH

Invitation Homes

$21.71

-0.07 (-0.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QTRH

Quarterhill

$0.95

-0.06 (-5.94%)

, CSCO

Cisco

$46.86

0.44 (0.95%)

06:33
12/11/18
12/11
06:33
12/11/18
06:33
Hot Stocks
Quarterhill subsidiary Wi-LAN grants patent license to Cisco »

Wi-LAN, a Quarterhill…

QTRH

Quarterhill

$0.95

-0.06 (-5.94%)

CSCO

Cisco

$46.86

0.44 (0.95%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 12

    Dec

  • 10

    Jan

ARNA

Arena Pharmaceuticals

$41.02

0.47 (1.16%)

06:33
12/11/18
12/11
06:33
12/11/18
06:33
Conference/Events
Arena Pharmaceuticals management to meet with Leerink »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

EQT

EQT Corporation

$19.61

1.19 (6.46%)

06:32
12/11/18
12/11
06:32
12/11/18
06:32
Hot Stocks
EQT postpones 2019 capital program and updated analyst presentation »

EQT Corporation's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

VIVHY

Vivendi

$0.00

(0.00%)

, TI

Telecom Italia

$6.24

-0.04 (-0.64%)

06:31
12/11/18
12/11
06:31
12/11/18
06:31
Hot Stocks
Vivendi calls for shareholders meeting to change Telecom Italia board »

The company said,…

VIVHY

Vivendi

$0.00

(0.00%)

TI

Telecom Italia

$6.24

-0.04 (-0.64%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VSM

Versum Materials

$31.22

-0.34 (-1.08%)

06:30
12/11/18
12/11
06:30
12/11/18
06:30
Downgrade
Versum Materials rating change  »

Versum Materials…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FIS

FIS

$105.72

1.07 (1.02%)

06:30
12/11/18
12/11
06:30
12/11/18
06:30
Upgrade
FIS rating change  »

FIS upgraded to Buy at…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 13

    Dec

NSANY

Nissan

$0.00

(0.00%)

06:27
12/11/18
12/11
06:27
12/11/18
06:27
Periodicals
Court rejects former Nissan chairman's appeal to end detention, Reuters reports »

A Tokyo court rejected…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jan

VNDA

Vanda Pharmaceuticals

$28.66

1.1 (3.99%)

06:27
12/11/18
12/11
06:27
12/11/18
06:27
Downgrade
Vanda Pharmaceuticals rating change  »

Vanda Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APEI

American Public Education

$28.97

-0.06 (-0.21%)

06:26
12/11/18
12/11
06:26
12/11/18
06:26
Conference/Events
American Public Education management to meet with Barrington »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

ACOR

Acorda Therapeutics

$19.08

0.48 (2.58%)

06:25
12/11/18
12/11
06:25
12/11/18
06:25
Downgrade
Goldman downgrades Acorda Therapeutics to Sell with $10 price target »

Goldman Sachs analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jan

ANGO

AngioDynamics

$20.90

0.11 (0.53%)

06:25
12/11/18
12/11
06:25
12/11/18
06:25
Conference/Events
AngioDynamics management to meet with KeyBanc »

Meeting to be held in the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 04

    Jan

FISV

Fiserv

$76.15

1.42 (1.90%)

06:25
12/11/18
12/11
06:25
12/11/18
06:25
Upgrade
Fiserv rating change  »

Fiserv upgraded to Buy at…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UAA

Under Armour

$22.39

-1.06 (-4.52%)

06:22
12/11/18
12/11
06:22
12/11/18
06:22
Conference/Events
Under Armour to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 14

    Dec

FDX

FedEx

$192.94

-8.31 (-4.13%)

, UPS

UPS

$104.42

-0.9 (-0.85%)

06:22
12/11/18
12/11
06:22
12/11/18
06:22
Periodicals
Trump admin proposal would let Postal Service sell mailbox access, WSJ reports »

The Trump administration…

FDX

FedEx

$192.94

-8.31 (-4.13%)

UPS

UPS

$104.42

-0.9 (-0.85%)

AMZN

Amazon.com

$1,640.37

11.18 (0.69%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 13

    Dec

  • 19

    Dec

  • 20

    Dec

CVON

ConvergeOne

$12.50

0.04 (0.32%)

06:19
12/11/18
12/11
06:19
12/11/18
06:19
Hot Stocks
ConvergeOne to acquire solutions integrator VT Consolidated »

ConvergeOne announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 19

    Dec

  • 20

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.